Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators test the hypothesis that different beta-blockers had a different influence on chemoreceptor response and lung diffusion capacity.

Both could influence exercise capacity in normoxic as well as hypoxic conditions.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centro Cardiologico Monzino
• Treatments: Bisoprolol; Carvedilol; Nebivolol

Criteria

Inclusion Criteria:

• Chronic heart failure patients in stable clinical condition

Exclusion Criteria:

• No comorbidity

• NYHA class IV